Finance

Lists
301408:SHE
Anhui Huaren Health Pharmaceuticl Co Ltd
CNÂ¥14.50
+0.69%
(+0.10) 1D
Sep 7, 11:47:34 AM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 301408...
Open
CNÂ¥14.40
High
CNÂ¥14.61
Low
CNÂ¥14.37
Mkt. cap
5.76B
Avg. vol.
17.00M
Volume
2.97M
Dividend
0.69%
Quarterly dividend
CNÂ¥0.03
Ex-dividend date
May 27, 2026
P/E ratio
25.95
52-wk high
CNÂ¥29.76
52-wk low
CNÂ¥12.17
EPS
CNÂ¥0.56
Shares outstanding
400.01M
No. of employees
9K
Open
CNÂ¥14.40
High
CNÂ¥14.61
Low
CNÂ¥14.37
Mkt. cap
5.76B
Avg. vol.
17.00M
Volume
2.97M
Dividend
0.69%
Quarterly dividend
CNÂ¥0.03
Ex-dividend date
May 27, 2026
P/E ratio
25.95
52-wk high
CNÂ¥29.76
52-wk low
CNÂ¥12.17
EPS
CNÂ¥0.56
Shares outstanding
400.01M
No. of employees
9K
About Anhui Huaren Health Pharmaceuticl Co Ltd
CEO-
Employees8.94K
FoundedJun 29, 2001
Headquarters-
SectorDrug
Websitehrjkjt.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
1.39B
1.59B
1.42B
1.40B
Cost of goods sold
920.83M
1.04B
921.66M
922.41M
Cost of revenue
920.83M
1.04B
921.66M
922.41M
Research and development expenses
9.69M
7.03M
9.56M
7.16M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
359.24M
396.06M
360.23M
373.25M
Operating expense
372.83M
419.52M
376.51M
381.82M
Total operating expenses
1.29B
1.46B
1.30B
1.30B
Operating income
94.90M
135.33M
122.81M
99.48M
Other non operating income
-8.66M
6.60M
-5.04M
-14.09M
EBT including unusual items
74.84M
72.04M
110.79M
89.51M
EBT excluding unusual items
88.92M
127.41M
115.92M
88.95M
Income tax expense
15.13M
29.57M
24.71M
27.19M
Effective tax rate
20.22%
41.04%
22.30%
30.38%
Other operating expenses
1.12M
8.89M
4.42M
3.70M
Net income
52.98M
34.63M
79.34M
56.57M
Net profit margin
3.82%
2.17%
5.58%
4.03%
Earnings per share
-
-
-
-
Interest and investment income
2.65M
5.74M
2.32M
4.17M
Interest expense
-
-20.14M
-4.17M
-617.68K
Net interest expenses
2.65M
-14.40M
-1.86M
3.55M
Depreciation and amortization charges
-
-
-
-
EBITDA
104.62M
146.42M
133.90M
111.53M
Gain or loss from assets sale
1.99M
-3.74M
-
-1.58M
AI content may include mistakes. Learn more
Google apps